OR WAIT null SECS
July 08, 2021
LGM Pharma will offer contract analytical testing and stability services to pharmaceutical developers and manufacturers.
July 03, 2021
The ever-increasing complexity of biotherapeutic molecules presents unique analytical challenges for developers.
The future pipeline of complex novel biotherapeutics will require new approaches to analytical assessment.
July 01, 2021
Developing bioassay methods requires a new approach for cell and gene therapy drug development.
June 30, 2021
Chalmers University researchers have developed a method to label and track mRNA molecules.
June 02, 2021
Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.
May 16, 2021
The sensitivity of droplet digital PCR helps manufacturers detect Mycoplasma contamination in AAV-based gene therapy products.
May 02, 2021
Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.
April 02, 2021
A well-chosen replication strategy can effectively reduce the uncertainty for an analytical method, enabling appropriate decisions regarding pharmaceutical quality.
Despite its importance in drug development, dissolution testing still has some limitations, but advances in automation and real-time monitoring are producing promising results.